WebAug 1, 2024 · Get the latest CTI BioPharma Corp. (CTIC) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals. ... Financials … WebApr 8, 2024 · CTI BioPharma last announced its earnings data on March 6th, 2024. The biopharmaceutical company reported ($0.14) earnings per share (EPS) for the quarter, …
CTIC Insider Trading Activity CTI BioPharma Insider Buys and Sells
WebStock Quote. Change Volume 52 Week High 52 Week Low Apr 13, 2024 1:41 PM EDT. Data Provided by Refinitiv. ... Wash. , April 12, 2024 /PRNewswire/ -- CTI BioPharma Corp. (Nasdaq: CTIC), a commercial biopharmaceutical company focused on the development and commercialization of novel targeted therapies for blood-related cancers, today … literary ethnography
CTIC - CTI Biopharma Corp Forecast - CNNMoney.com
WebOn Mar 06, 2024, Cti Biopharma ( NASDAQ: CTIC) reported Q4 2024 earnings per share (EPS) of -$0.12, up 69.23% year over year. Total Cti Biopharma earnings for the quarter were -$17.46 million. In the same quarter last year, Cti Biopharma 's earnings per share (EPS) was -$0.39. If you're new to stock investing, here's how to buy Cti Biopharma stock. WebMar 10, 2024 · CTIC: Get the latest CTI BioPharma stock price and detailed information including CTIC news, historical charts and realtime prices. ... Earnings Report-0.099 USD : Q1 2024 Earnings Release: 05/04 ... WebMar 17, 2024 · CTI BioPharma ( NASDAQ:CTIC – Get Rating) last issued its quarterly earnings data on Monday, March 6th. The biopharmaceutical company reported ($0.14) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.04). CTI BioPharma had a negative net margin of 172.37% and a negative return on … importance of section modulus